IMTX – immatics n.v. - ordinary shares (US:NASDAQ)

News

Immatics (IMTX) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Immatics Phase 3 Progress Sharpens View On Anzu Cel Launch Upside [Yahoo! Finance]
Immatics N.V. (IMTX) Seeing Strong Enrollment in a Key Phase 3 Trial of Drug Candidate [Yahoo! Finance]
Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot [Seeking Alpha]
Immatics (IMTX) was upgraded by Wall Street Zen from "sell" to "hold"
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com